106 related articles for article (PubMed ID: 32703059)
21. Acceptability and feasibility of a community based participatory research project comparing cytology and urine HPV DNA testing for cervical cancer screening in Yap, Federated States of Micronesia.
Sy AU; Hernandez BY; Tareg A; Reichhardt M; Buenconsejo-Lum L
Cancer Epidemiol; 2017 Oct; 50(Pt B):283-288. PubMed ID: 29120838
[TBL] [Abstract][Full Text] [Related]
22. A randomized, controlled trial of two strategies of offering the home-based HPV self-sampling test to non- participants in the Flemish cervical cancer screening program.
Kellen E; Benoy I; Vanden Broeck D; Martens P; Bogers JP; Haelens A; Van Limbergen E
Int J Cancer; 2018 Aug; 143(4):861-868. PubMed ID: 29569715
[TBL] [Abstract][Full Text] [Related]
23. Self-collection for high-risk HPV detection in Brazilian women using the careHPV™ test.
Lorenzi AT; Fregnani JH; Possati-Resende JC; Neto CS; Villa LL; Longatto-Filho A
Gynecol Oncol; 2013 Oct; 131(1):131-4. PubMed ID: 23880151
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of the effectiveness of high-risk human papilloma self-sampling test for cervical cancer screening in Bolivia.
Allende G; Surriabre P; Ovando N; Calle P; Torrico A; Villarroel J; Bossens M; Fontaine V; Rodriguez P
BMC Infect Dis; 2020 Apr; 20(1):259. PubMed ID: 32245369
[TBL] [Abstract][Full Text] [Related]
25. Cervical cancer screening and subsequent procedures in women under the age of 25 years between 2007 and 2013 in France: a nationwide French healthcare database study.
Maura G; Chaignot C; Weill A; Alla F; Heard I
Eur J Cancer Prev; 2018 Sep; 27(5):479-485. PubMed ID: 28368950
[TBL] [Abstract][Full Text] [Related]
26. Rationale and design of the HOME trial: A pragmatic randomized controlled trial of home-based human papillomavirus (HPV) self-sampling for increasing cervical cancer screening uptake and effectiveness in a U.S. healthcare system.
Winer RL; Tiro JA; Miglioretti DL; Thayer C; Beatty T; Lin J; Gao H; Kimbel K; Buist DSM
Contemp Clin Trials; 2018 Jan; 64():77-87. PubMed ID: 29113956
[TBL] [Abstract][Full Text] [Related]
27. Perspectives from health-care providers and women about completing human papillomavirus (HPV) self-testing at home.
Katz ML; Zimmermann BJ; Moore D; Paskett ED; Reiter PL
Women Health; 2017; 57(10):1161-1177. PubMed ID: 27700693
[TBL] [Abstract][Full Text] [Related]
28. Cervical Cancer Screening Preferences Among Trans-Masculine Individuals: Patient-Collected Human Papillomavirus Vaginal Swabs Versus Provider-Administered Pap Tests.
McDowell M; Pardee DJ; Peitzmeier S; Reisner SL; Agénor M; Alizaga N; Bernstein I; Potter J
LGBT Health; 2017 Aug; 4(4):252-259. PubMed ID: 28665783
[TBL] [Abstract][Full Text] [Related]
29. Community-Based Screening for Cervical Cancer: A Feasibility Study of Rural Appalachian Women.
Crosby RA; Hagensee ME; Vanderpool R; Nelson N; Parrish A; Collins T; Jones N
Sex Transm Dis; 2015 Nov; 42(11):607-11. PubMed ID: 26462184
[TBL] [Abstract][Full Text] [Related]
30. Impact of human papillomavirus (HPV) self-collection on subsequent cervical cancer screening completion among under-screened US women: MyBodyMyTest-3 protocol for a randomized controlled trial.
Spees LP; Des Marais AC; Wheeler SB; Hudgens MG; Doughty S; Brewer NT; Smith JS
Trials; 2019 Dec; 20(1):788. PubMed ID: 31881928
[TBL] [Abstract][Full Text] [Related]
31. Human Papilloma Virus self-sampling performance in low- and middle-income countries.
Kamath Mulki A; Withers M
BMC Womens Health; 2021 Jan; 21(1):12. PubMed ID: 33407355
[TBL] [Abstract][Full Text] [Related]
32. Home-based HPV self-sampling improves participation by never-screened and under-screened women: Results from a large randomized trial (iPap) in Australia.
Sultana F; English DR; Simpson JA; Drennan KT; Mullins R; Brotherton JM; Wrede CD; Heley S; Saville M; Gertig DM
Int J Cancer; 2016 Jul; 139(2):281-90. PubMed ID: 26850941
[TBL] [Abstract][Full Text] [Related]
33. Urinary HPV DNA testing as a tool for cervical cancer screening in women who are reluctant to have a Pap smear in France.
Lefeuvre C; Pivert A; Guillou-Guillemette HL; Lunel-Fabiani F; Veillon P; Le Duc-Banaszuk AS; Ducancelle A
J Infect; 2020 Aug; 81(2):248-254. PubMed ID: 32413363
[TBL] [Abstract][Full Text] [Related]
34. Knowledge and attitudes about human papillomavirus, Pap smears, and cervical cancer among young women in Brazil: implications for health education and prevention.
Moreira ED; Oliveira BG; Ferraz FM; Costa S; Costa Filho JO; Karic G
Int J Gynecol Cancer; 2006; 16(2):599-603. PubMed ID: 16681732
[TBL] [Abstract][Full Text] [Related]
35. Acceptability of self-collected versus provider-collected sampling for HPV DNA testing among women in rural El Salvador.
Rosenbaum AJ; Gage JC; Alfaro KM; Ditzian LR; Maza M; Scarinci IC; Felix JC; Castle PE; Villalta S; Miranda E; Cremer ML
Int J Gynaecol Obstet; 2014 Aug; 126(2):156-60. PubMed ID: 24880188
[TBL] [Abstract][Full Text] [Related]
36. Can self vaginal douching for high risk HPV screening replace or assist efficacy of cervical cancer screening?
Suwannarurk K; Bhamarapravatana K; Kheolamai P; Thaweekul Y; Mairaing K; Poomtavorn Y; Pattaraarchachai J
Asian Pac J Cancer Prev; 2010; 11(5):1397-401. PubMed ID: 21198300
[TBL] [Abstract][Full Text] [Related]
37. Risk Behaviors Correlate with Higher Prevalence of Papanicolaou, Human Papillomavirus, and Human Immunodeficiency Virus Screening Among Women in the United States.
Merrill RM; Williams EN; Fuhriman H
J Womens Health (Larchmt); 2021 Apr; 30(4):615-624. PubMed ID: 33085563
[No Abstract] [Full Text] [Related]
38. Evaluation of the Impact of Human Papillomavirus DNA Self-sampling on the Uptake of Cervical Cancer Screening.
Wong EL; Chan PK; Chor JS; Cheung AW; Huang F; Wong SY
Cancer Nurs; 2016; 39(1):E1-E11. PubMed ID: 25730587
[TBL] [Abstract][Full Text] [Related]
39. Acceptability of Self-Sampling for Human Papillomavirus-Based Cervical Cancer Screening.
Chatzistamatiou K; Vrekoussis T; Tsertanidou A; Moysiadis T; Mouchtaropoulou E; Pasentsis K; Kitsou A; Moschaki V; Ntoula M; Zempili P; Halatsi D; Truva T; Piha V; Agelena G; Daponte A; Vanakara P; Paschopoulos M; Stefos T; Lymberis V; Kontomanolis EN; Makrigiannakis A; Deligeoroglou E; Panoskaltsis T; Adonakis G; Michail G; Stamatopoulos K; Agorastos T
J Womens Health (Larchmt); 2020 Nov; 29(11):1447-1456. PubMed ID: 32757997
[No Abstract] [Full Text] [Related]
40. Prior high-risk HPV testing and Pap test results for 427 invasive cervical cancers in China's largest CAP-certified laboratory.
Zheng B; Li Z; Griffith CC; Yan S; Chen C; Ding X; Liang X; Yang H; Zhao C
Cancer Cytopathol; 2015 Jul; 123(7):428-34. PubMed ID: 25954852
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
